#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchopulmonary dysplasia Autoimmune hepatitis Pyruvate kinase deficiency anaemia Leukocyte adhesion deficiency type I Hydrocephalus Cystic fibrosis gastrointestinal disease Juvenile idiopathic arthritis Thyroid cancer metastatic Ocular myasthenia Exudative retinopathy Non-small cell lung cancer metastatic Neoplasm malignant Haemophagocytic lymphohistiocytosis Hepatocellular carcinoma Ichthyosis More trials…

    Learn about Rare Diseases

    Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Lymphatic malformation – Diagnostics Rett syndrome Factor VIII deficiency – Trials in Disease Pemphigus Cholangitis sclerosing – Trials in Disease Uterine leiomyosarcoma Hereditary angioedema with C1 esterase inhibitor deficiency Pleural mesothelioma malignant – Life with Disease Mucous membrane pemphigoid – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enx-101 Thiopental Sodium Azd7798 Talazoparib Buprenorphine SECRETIN SYNTHETIC HUMAN Azd8630 Certolizumab Pegol Sodium Iodide (123 I) Cd19-Car_Lenti_Allo Zanubrutinib A49 Neridronate Sodium Fluvastatin Idarubicin AMO959 Sargramostim Efpegerglucagon Wt1 Mrna Dc Brinzolamide More therapies…

    Learn about Your Condition

    Fabry's disease Hypotension Malignant fibrous histiocytoma Cardiac disorder Colour blindness Intestinal obstruction Systemic sclerosis pulmonary Psychotic behaviour Femoral hernia Hypochondroplasia Biliary neoplasm EGFR gene mutation Retinal artery occlusion Cutaneous T-cell lymphoma Bladder cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Rezvilutamide and Bicalutamide with Hormone Therapy for Patients with Advanced Prostate Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Rezvilutamide
    • Bicalutamide
    • Goserelin
    Bulgaria Czechia Poland

  • Study on Antibiotic Treatments for Kidney Infection in Children: Comparing Cefixime, Ceftriaxone, and Amikacin for Ages 1 Month to 3 Years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyelonephritis acute
    Investigated Drugs:
    • Cefixime Trihydrate
    • Lidocaine Hydrochloride
    • Amikacin Sulfate
    France

  • Study on Short vs. Standard Amoxicillin Treatment for Adults with Lower Limb Erysipelas

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyoderma
    Investigated Drugs:
    • Amoxicillin Sodium
    France

  • Study on the Effects of Sabirnetug for Patients with Early Alzheimer’s Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Sabirnetug
    • Florbetaben (18F)
    • Florbetapir (18F)
    France Germany Spain

  • Study of GBT021601 for Adults and Children with Sickle Cell Disease

    Not yet recruiting

    4 1
    Investigated Drugs:
    • (S)-2-Hydroxy-6-((4-(2-(2-Hydroxyethyl)Nicotinoyl)Morpholin-3-Yl)Methoxy)Benzaldehyde
    France Germany Greece

  • Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Lutikizumab
    • Adalimumab
    Austria Belgium Bulgaria Croatia Estonia France +12
Previous Page
1 … 833 834 835 836 837 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!